心臓電気生理学的検査における抗不整脈薬の管理:段階的アプローチ
Giacomo Mugnai1, Davide Genovese2, Francesco Santoro3
1Division of Cardiology, Cardio-Thoracic Department, University Hospital of Verona, Verona, Italy.
Journal of cardiovascular electrophysiology
|February 8, 2026
まとめ
心臓電気生理学的検査(EP検査)の前に抗不整脈薬(AAD)を中止するには、薬剤の消失期間を慎重に考慮する必要があります。このレビューは、正確な診断とEP検査の成功を確実にするためのAAD休薬に関するガイダンスを提供します。
科学分野:
- 循環器病学
- 臨床薬理学
背景:
- 抗不整脈薬(AAD)は、介入的心臓電気生理学的検査(EP検査)における診断精度と処置成功を妨げる可能性がある。
- 効果的なEP検査には、薬剤を使用しないベースラインを確立することが不可欠である。
研究 の 目的:
- EP検査前のAAD中止に関するプロトコルと根拠をレビューする。
- 安全性と成功率を向上させるためのAAD休薬の標準化に関するエビデンスに基づいたガイダンスを提供する。
主な方法:
- 様々な不整脈に対する処置特異的なAAD休薬要件の分析。
- 薬物動態および薬力学の原理に基づいて休薬期間を計算するための薬剤ごとのガイドの開発。
主要な成果:
- 主要なAADクラスの半減期、代謝、排泄経路に関する詳細なガイド。
- 年齢、腎機能、肝機能などの患者固有の要因に基づいて休薬期間を調整するための推奨事項。
結論:
- 標準化されたAAD休薬プロトコルは、介入的心臓電気生理学的検査に不可欠である。
- AAD休薬に関する臨床医へのガイダンスは、診断精度と処置結果を向上させることができる。
関連する概念動画
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.9K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.9K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
3.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.5K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.5K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.2K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.2K
Frustration and Conflict: Approach-Approach, Approach-Avoidance
540
Frustration occurs when people are obstructed or prevented from achieving a desired goal or fulfilling a perceived need. For example, when someone's input is ignored in a discussion, it can lead to feelings of frustration. Conflict, however, arises from opposing interests, goals, or actions. Conflicts can take various forms based on the nature of these opposing desires or goals.
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
540
Tonsillitis II: Management
443
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
443


